X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 58 filers reported holding X4 PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 5.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,174,690 | -67.7% | 1,995,128 | -42.5% | 0.00% | -100.0% |
| Q2 2023 | $6,731,216 | +4706.8% | 3,469,699 | +2055.6% | 0.00% | – |
| Q1 2023 | $140,036 | -87.5% | 160,961 | -85.7% | 0.00% | – |
| Q4 2022 | $1,120,455 | +463.0% | 1,128,353 | +867.7% | 0.00% | – |
| Q3 2022 | $199,000 | +101.0% | 116,600 | +14.1% | 0.00% | – |
| Q2 2022 | $99,000 | -59.6% | 102,154 | -27.0% | 0.00% | – |
| Q1 2022 | $245,000 | -35.5% | 140,014 | -15.7% | 0.00% | – |
| Q4 2021 | $380,000 | +7.0% | 166,000 | +148.0% | 0.00% | – |
| Q3 2021 | $355,000 | -22.3% | 66,932 | -4.8% | 0.00% | – |
| Q2 2021 | $457,000 | +294.0% | 70,273 | +505.7% | 0.00% | – |
| Q1 2020 | $116,000 | – | 11,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |